AUG 04, 2019 8:04 AM PDT

The anti-cancer flower

Perhaps you have heard of feverfew, a quite common flowering plant that graces many home gardens. Its cute white petals may bring a smile to your lips – but did you know that it has hidden within it an anti-cancer compound?

New research from the University of Birmingham and published in MedChemComm shows that in addition to acting as a natural remedy for fevers, migraine headaches, rheumatoid arthritis, stomach aches, and toothaches, among other symptoms, feverfew is also capable of killing chronic lymphocytic leukaemia (CLL) cells.

Researchers from the University's Institute of Cancer and Genomic Studies, the School of Chemistry and the drug discovery services companies, Sygnature Discovery and Apconix collaborated with the University of Birmingham's Winterbourne Botanic Garden to cultivate enough feverfew plants to conduct the study. While previous studies had identified the compound found in the plant, called parthenolide, it is currently only available commercially at an outrageously high price and still not very effective.

The research team wanted to change that so they set out to find a way to produce the parthenolide directly from plants, as well as a way to alter it so that the plant produces several other compounds that were shown to kill cancer cells in in vitro experiments. While still only demonstrated in a laboratory setting, the finding could have significant impacts on development of treatments for chronic lymphocytic leukaemia (CLL) therapies.

A researcher on the study, Dr. Angelo Agathanggelou, of the Institute of Cancer and Genomic Studies, clarified: "There are several effective treatments for CLL, but after a time the disease in some patients becomes resistant. We were interested in finding out more about the potential of parthenolide. With expertise from colleagues in the School of Chemistry we've been able to demonstrate that this compound shows real promise and could provide alternative treatment options for CLL patients."

Inside feverfew hides a compound with anti-cancer properties. Photo: Pixabay

Another researcher on the study, Professor John Fossey, commented: "This research is important not only because we have shown a way of producing parthenolide that could make it much more accessible to researchers, but also because we've been able to improve its "drug-like" properties to kill cancer cells. It's a clear demonstration that parthenolide has the potential to progress from the flowerbed into the clinic."

Parthenolide works by raising the levels of reactive oxygen species (ROS) in cells, essentially pushing ROS levels to an unsustainable level in cancer cells until the cell cannot survive and dies.

Sources: Science Daily, MedChemComm

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
NOV 18, 2019
Cancer
NOV 18, 2019
UV light targets hyperhotspots for skin cancer
New research published in Proceedings of the National Academy of Sciences suggests that certain “hyperhotspots” in the human genome can be pinp...
NOV 23, 2019
Cancer
NOV 23, 2019
Anal cancer rates increase twofold
Anal cancer has been on the rise in the United States, and while it may not garner as much attention as other cancers, mortality rates for anal cancer have...
DEC 13, 2019
Cancer
DEC 13, 2019
Physical exercise could halve the risk of prostate cancer
New research suggests physical activity could act as a tool to prevent increased risk for prostate cancer. The research comes from scientists at the U...
JAN 05, 2020
Cancer
JAN 05, 2020
Good news for patients with testicular cancer!
Good news for patients with testicular cancer! A new clinical trial has shown that using just half of the quantity of chemotherapy traditionally administer...
JAN 08, 2020
Health & Medicine
JAN 08, 2020
Cancer Death Rates Declining in U.S., According to New Report
In the United States, the death rate from cancer has declined, according to a new report released today by the American Cancer Society. The video below sum...
FEB 16, 2020
Cell & Molecular Biology
FEB 16, 2020
Growing Cells on Scaffolding as an Alternative to Animal Models
Researchers may have just made it easier for investigators to switch to an engineered model and replace their animal colonies with electrospun synthetics....
Loading Comments...